Nuvalent (NUVL) Accumulated Expenses (2020 - 2026)
Nuvalent (NUVL) posted Accumulated Expenses of $8.2 million for Q1 2026, down 86.54% on a QoQ basis from $61.0 million in Q4 2025, and down 83.19% year-over-year from $48.9 million in Q1 2025.
Nuvalent (NUVL) Accumulated Expenses (2020 - 2026) Analysis & Trends
Nuvalent's Accumulated Expenses history runs 7 years deep, the most recent figure standing at $8.2 million for Q1 2026.
- Quarterly Accumulated Expenses fell 83.19% year-over-year to $8.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.2 million (down 83.19% YoY) and the FY2025 annual result came in at $61.0 million, up 483.74% from the prior year.
- Accumulated Expenses was $8.2 million for Q1 2026 at Nuvalent, down from $61.0 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $61.8 million in Q2 2025 and bottomed at $3.9 million in Q1 2022.
- A 5-year average of $21.7 million and a median of $12.3 million in 2022 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2025 — Accumulated Expenses jumped 483.74% — and 2026, when it slumped 83.19%.
- Nuvalent's Accumulated Expenses stood at $12.3 million in 2022, then plunged by 40.37% to $7.3 million in 2023, then jumped by 42.67% to $10.5 million in 2024, then soared by 483.74% to $61.0 million in 2025, then slumped by 86.54% to $8.2 million in 2026.
- Business Quant data shows NUVL's Accumulated Expenses at $8.2 million in Q1 2026, $61.0 million in Q4 2025, and $11.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.21 Mn |
| Dec 31, 2025 | 61.01 Mn |
| Sep 30, 2025 | 11.82 Mn |
| Jun 30, 2025 | 61.81 Mn |
| Mar 31, 2025 | 48.87 Mn |
| Dec 31, 2024 | 10.45 Mn |
| Sep 30, 2024 | 35.20 Mn |
| Jun 30, 2024 | 30.79 Mn |
| Mar 31, 2024 | 20.03 Mn |
| Dec 31, 2023 | 7.33 Mn |
| Sep 30, 2023 | 19.32 Mn |
| Jun 30, 2023 | 12.68 Mn |
| Mar 31, 2023 | 10.59 Mn |
| Dec 31, 2022 | 12.29 Mn |
| Sep 30, 2022 | 8.36 Mn |
| Jun 30, 2022 | 6.01 Mn |
| Mar 31, 2022 | 3.88 Mn |
| Dec 31, 2021 | 5.89 Mn |
| Sep 30, 2021 | 4.31 Mn |
| Jun 30, 2021 | 2.03 Mn |